We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FTC Advisory Opinion Approves Drug Shortage Initiative

30 August 2012

Competition-USA

On August 8 2012 the Federal Trade Commission (FTC) issued an advisory letter which concluded that an initiative proposed by the Generic Pharmaceutical Association to address drug shortages is unlikely to harm competition. The advisory opinion was issued in response to the association's request for review of its proposed accelerated recovery initiative, pursuant to which manufacturers of generic drugs in short supply will compile competitively sensitive information and provide it to the US Food and Drug Administration (FDA) in order to help the FDA to address drug shortages.

Read more: FTC Advisory Opinion Approves Drug Shortage Initiative

The team

Loading data